Abstract | BACKGROUND: Recently, 5-aminolevulinic acid (5-ALA), precursors of protoporphyrin IX ( PpIX), and Sn(IV) chlorin e6 ( SnCe6) have been proposed as possible sonosensitizers for sonodynamic therapy of cancer. Therefore, we evaluated the pharmacokinetic properties and sonosensitizing activities of 5-ALA and SnCe6 in vivo by using the EMT6/KU tumor-bearing chick embryos. RESULTS: The concentration of PpIX in tumor and liver tissues and serum increased in a time-dependent manner after the i.v. administration of 5-ALA; PpIX concentrations reached their peak level after 5-7 h. The concentration of SnCe6 reached its maximum value in the tumor tissue and serum immediately after i.v. administration. The combined treatment of 5-ALA or SnCe6 with ultrasound irradiation showed a significant antitumor effect towards EMT6/KU solid tumors. CONCLUSION: We evaluated the pharmacokinetic properties and sonosensitizing activities of 5-ALA and SnCe6 in a chick embryo model and found that 5-ALA might be more suitable as a sonosensitizer than SnCe6.
|
Authors | Yoshihiro Uto, Dai Tamatani, Yusuke Mizuki, Yoshio Endo, Ikuo Nakanishi, Kei Ohkubo, Shunichi Fukuzumi, Masahiro Ishizuka, Tohru Tanaka, Daisuke Kuchiike, Kentaro Kubo, Toshio Inui, Hitoshi Hori |
Journal | Anticancer research
(Anticancer Res)
Vol. 34
Issue 8
Pg. 4583-7
(Aug 2014)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 25075103
(Publication Type: Journal Article)
|
Copyright | Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- Metalloporphyrins
- Protoporphyrins
- tin(IV) chlorin e6
- Aminolevulinic Acid
- protoporphyrin IX
|
Topics |
- Aminolevulinic Acid
(pharmacokinetics, pharmacology)
- Animals
- Cell Line, Tumor
- Chick Embryo
- Metalloporphyrins
(pharmacokinetics, pharmacology)
- Mice
- Neoplasms, Experimental
(therapy)
- Protoporphyrins
(metabolism)
- Ultrasonic Therapy
|